MedMen Announces Permanent Appointment of Tom Lynch as Chief Executive Officer
LOS ANGELES–(COMMERCIAL THREAD) – MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced that the current Interim Chief Executive Officer and Chairman of the Board of Directors of MedMen, Tom Lynch, will be appointed to the position of Permanent Chief Executive Officer of the Company effective Thursday, July 15, 2021. Lynch has served as Interim Chief Executive Officer since March 2020.
“I am delighted to join MedMen on a more permanent basis”, said Lynch. “We have an incredible opportunity to capitalize on our recent successes and continue on the path of rapid growth and profitability. Our goal is to solidify MedMen’s place as a premier cannabis retailer and to continue expanding our retail footprint to ensure that everyone has access to the highest quality and most effective cannabis products. on the market today.
MedMen is a leading US cannabis retailer with an operational presence in California, Nevada, Illinois, Arizona, Massachusetts and Florida. MedMen offers a robust selection of high quality products including brands owned by MedMen [statemade], LuxLyte and MedMen Red through its premium retail stores, exclusive delivery service, as well as curbside and in-store pickup. MedMen Buds, the industry’s premier loyalty program, offers exclusive access to promotions, products and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen at www.medmen.com.
Caution regarding forward-looking information and statements:
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of US Private Securities Litigation. Reform Act. from 1995. These forward-looking information and forward-looking statements are not representative of historical facts or information or the current state of affairs, but only represent MedMen’s beliefs regarding future events, plans or objectives, many of which by their nature. nature, are inherently uncertain and beyond MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terms such as “look ahead”, “continue” and “stay”. This forward-looking information is based on certain assumptions made by management and on other factors used by management in preparing this information.
Forward-looking information and statements are not based on historical facts but are rather based on assumptions, estimates, analyzes and opinions of the management of the Company at the time they were provided or made in light of its experience. and its perception of trends, current conditions and expected developments, as well as other factors that management considers relevant and reasonable in the circumstances and are subject to inherent risks and uncertainties which may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be correct, that the assumptions may not be correct and that the objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from forward-looking statements contained in this press release and other reports we file or provide. at the SEC and other regulatory bodies and carried out by our directors, officers, other employees and others authorized to speak on our behalf. These factors include, but are not limited to: (i) the ability to effectively manage the restrictions, limitations and health issues presented by the COVID-19 pandemic; (ii) management’s perceptions of historical trends, current conditions and expected future developments; (iii) development costs remaining consistent with budgets, (iv) the ability to effectively manage growth, including anticipated and unforeseen costs; (v) achieve the expected results of the Company’s strategic plans; (vi) the adequacy of our capital resources and liquidity, including, but not limited to, the availability of sufficient cash flows to execute our business plan (either on schedule or not all) ; (vii) the ability to raise the necessary or desired funds to achieve our strategic business plan; (viii) obtain and retain all required licenses, approvals and permits; (ix) favorable production levels and sustainable costs; (x) inputs, suppliers and skilled labor being unavailable or available only at uneconomic costs; (xi) material and technology supply chain disruptions for leasehold improvements and regulatory approval timing related to new and expanded retail stores, including the expansion to Oak Park, IL; (xii) unfavorable future legislative and regulatory developments relating to medical and recreational marijuana; (xiii) consumer interest in our products and the products of other brands that we carry in our stores; (xiv) competition; (xv) government regulation of our business and products, including, but not limited to, the areas of taxation and environmental protection; (xvi) the risks of operating in the marijuana industry in the United States; (xvii) the outcome of any claim, dispute and proceeding to which we are a party, including any pending settlement or regulatory action against us or other legal contingencies; (xviii) our ability to conduct operations in a safe, efficient and effective manner; (xix) changes in the economic, business and general political conditions in which we operate, including changes in financial markets; changes in applicable laws in general and (xx) and other risk factors discussed in MedMen’s Form 10 (as amended), and other continuous disclosure documents, all available under MedMen’s profile on www.sedar.com and to www.sec.gov.
Although MedMen believes that the assumptions and factors used in the preparation, and the expectations contained in, the forward-looking information and statements are reasonable, such information and statements should not be trusted unduly, and no assurances or guarantees can be made. given that this forward-looking information will prove to be correct, as actual results and future events could differ materially from those anticipated in such information and statements. If the assumptions underlying forward-looking statements prove to be incorrect, actual results could differ materially from those described in this document as intended, planned, anticipated, believed, estimated or expected.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and / or forward-looking statements that are contained or referenced in present, except in accordance with applicable securities laws.
The forward-looking statements contained in this press release are expressly qualified by this cautionary note.